Guru Ownership Trend
Guru Analysis for ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.95 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $6.4 M net inflow during the quarter.
Recent activity highlights Joel Greenblatt who dramatically increased their stake.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for ImmunityBio, Inc. (IBRX)
Major holders include Renaissance Technologies (RenTech) ($9.01 M), Cliff Asness ($1.95 M), Joel Greenblatt ($1.54 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.57 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $6.4 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited IBRX. The total reported sell value was $6.7 M.
Yes, 2 managers opened new positions in IBRX, and 2 increased their existing holdings. The total reported buy value was $13.1 M.